Specific [125I]-angiotensin binding to crude basolateral/brush border membranes of rat kidney cortex was influenced by guanine nucleotides. The order of potency of nucleotides in their ability to decrease specific binding, was Gpp(NH)p greater than GTP greater than or equal to ITP greater than GDP greater than ATP greater than GMP greater than IDP. The kinetic alterations induced by a maximally effective concentration of Gpp(NH)p were: (a) a reduced steady state level of binding and (b) a markedly slower rate of ligand dissociation. The presence of Gpp(NH)p was found to increase the affinity of [125I]-angiotensin binding sites in rat renal cortex membranes. This contrasts with the decreases in affinity of [125I]-angiotensin binding reported in adrenal and mesenteric artery membranes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0006-2952(83)90310-6DOI Listing

Publication Analysis

Top Keywords

[125i]-angiotensin binding
16
guanine nucleotides
8
rat kidney
8
kidney cortex
8
affinity [125i]-angiotensin
8
binding
6
greater
6
[125i]-angiotensin
4
nucleotides [125i]-angiotensin
4
binding rat
4

Similar Publications

Due to its high affinity for [(125)I]Angiotensin IV, cystinyl aminopeptidase (CAP) has recently been assigned as the 'angiotensin AT(4) receptor'. Since the aminopeptidase N (AP-N) activity is also susceptible to inhibition by Angiotensin IV, it might represent an additional target for this peptide. Based on [(125)I]Angiotensin IV binding and catalytic activity measurements, we compared the ligand interaction properties of recombinant human CAP and human AP-N.

View Article and Find Full Text PDF

Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters.

Vascul Pharmacol

April 2006

Department of Physiology, University of Puerto Rico, School of Medicine, GPO Box 365067, San Juan, PR 00936-5067, Puerto Rico.

Heart failure (HF) is a multifactorial and progressive disease that has been associated with multiple systemic and vascular alterations. Previous reports from our laboratory showed that in 2-month-old Bio-To2 Syrian cardiomyopathic hamsters (SCH) that have not yet developed the clinical manifestations of HF, the vascular contractility induced by 0.1 microM angiotensin II was approximately 35% greater than in control animals.

View Article and Find Full Text PDF

Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles.

Regul Pept

July 2005

Department of Pharmacology, Faculty of Medicine, National University of Singapore, 119260 Singapore.

The binding of 125I-[Sar1,Ile8]angiotensin II and 125I-angiotensin II to ventricular membranes of rat heart was studied. Displacement of bound 125I-[Sar1,Ile8]angiotensin II by its cold equivalents, angiotensin I, angiotensin II, angiotensin III, des-aspartate-angiotensin I, losartan, PD123319 and CGP42112B supports the presence of the AT1 and the near absence of the AT2 angiotensin receptor in adult rat ventricle. The presence of binding sites for des-aspartate-angiotensin I could account for its reported cardioprotective actions.

View Article and Find Full Text PDF

Metal ion modulation of cystinyl aminopeptidase.

Biochem J

August 2005

Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium.

Cystinyl aminopeptidase has one Zn2+-binding motif and is a member of the M1 aminopeptidase family. Ion modulation of its catalytic activity was studied in membranes of CHO-K1 cells (Chinese-hamster ovary K1 cells) using L-leucine-p-nitroanilide as substrate. The planar bidentate chelators 1,10-phenanthroline and 2,2'-bipyridine inhibited the activity in a concentration-dependent manner with Hill slopes of 3.

View Article and Find Full Text PDF

Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.

Hypertension

October 2004

Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Brazil.

It has been described recently that the nonpeptide AVE 0991 (AVE) mimics the effects of angiotensin-(1-7) [Ang-(1-7)] in bovine endothelial cells. In this study, we tested the possibility that AVE is an agonist of the Ang-(1-7) receptor Mas, in vitro and in vivo. In water-loaded C57BL/6 mice, AVE (0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!